

San Diego-based Erasca, a provider of precision cancer therapies, has raised $36 million in funding. The investors include Partner Fund Management and OrbiMed.
Source: Press Release
San Diego-based Erasca, a provider of precision cancer therapies, has raised $36 million in funding.
San Diego-based Erasca, a provider of precision cancer therapies, has raised $36 million in funding. The investors include Partner Fund Management and OrbiMed.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination